Literature DB >> 9690383

Suggestion against an oral-oral route of transmission for Helicobacter pylori infection: a seroepidemiological study in a rural area.

F Luzza1, M Imeneo, M Maletta, G Paluccio, S Nisticò, F Perticone, A Focà, F Pallone.   

Abstract

In this study the seroepidemiology of H. pylori and Epstein-Barr virus was compared in the same setting. A sample of 705 subjects completed a structured questionnaire. A serum sample was drawn from each subject and assayed for H. pylori IgG. Antibodies to Epstein-Barr virus were determined in a subgroup of 466 subjects. Cross-tabulation of data showed that 274 (58.8%) subjects were seropositive and 20 (4.3%) were seronegative for both infections, 17 (3.6%) were seropositive for H. pylori, and 155 (33.3%) were seropositive for Epstein-Barr virus (odds ratio=2.08, 95% confidence interval: 1.008-4.3). Nevertheless, the agreement between H. pylori and Epstein-Barr virus seropositivity was no better than chance (kappa=0.067) and the age-related seroprevalence curve of Epstein-Barr virus was similar in H. pylori seropositive and seronegative subjects. Furthermore, multiple logistic regression analysis did not show any risk factor shared by both infections. The findings of this study do not support the hypothesis that H. pylori and Epstein-Barr virus share a common mode of transmission. It can be speculated that the oral cavity may not be an important reservoir for H. pylori.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690383     DOI: 10.1023/a:1018802528986

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  A newly developed PCR assay of H. pylori in gastric biopsy, saliva, and feces. Evidence of high prevalence of H. pylori in saliva supports oral transmission.

Authors:  C Li; T Ha; D A Ferguson; D S Chi; R Zhao; N R Patel; G Krishnaswamy; E Thomas
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

Review 2.  Helicobacter pylori infection.

Authors:  C S Goodwin; M M Mendall; T C Northfield
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

3.  Evidence against an increased risk of Helicobacter pylori infection in dentists: a serological and salivary study.

Authors:  F Luzza; M Maletta; M Imeneo; E Fabiano; P Doldo; L Biancone; F Pallone
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-08       Impact factor: 2.566

Review 4.  Review article: is Helicobacter pylori transmitted by the gastro-oral route?

Authors:  A T Axon
Journal:  Aliment Pharmacol Ther       Date:  1995-12       Impact factor: 8.171

5.  Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR.

Authors:  N P Mapstone; D A Lynch; F A Lewis; A T Axon; D S Tompkins; M F Dixon; P Quirke
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

6.  Isolation of Helicobacter pylori from saliva.

Authors:  D A Ferguson; C Li; N R Patel; W R Mayberry; D S Chi; E Thomas
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

Review 7.  Transmission of Helicobacter pylori: faecal-oral versus oral-oral route.

Authors:  F Mégraud
Journal:  Aliment Pharmacol Ther       Date:  1995       Impact factor: 8.171

8.  High prevalence of Helicobacter pylori antibodies in an institutionalized population: evidence for person-to-person transmission.

Authors:  J R Lambert; S K Lin; W Sievert; L Nicholson; M Schembri; C Guest
Journal:  Am J Gastroenterol       Date:  1995-12       Impact factor: 10.864

9.  Helicobacter pylori infection in dental workers: a seroepidemiology study.

Authors:  H M Malaty; D J Evans; K Abramovitch; D G Evans; D Y Graham
Journal:  Am J Gastroenterol       Date:  1992-12       Impact factor: 10.864

10.  Evaluation of the polymerase chain reaction for detecting the urease C gene of Helicobacter pylori in gastric biopsy samples and dental plaque.

Authors:  J Bickley; R J Owen; A G Fraser; R E Pounder
Journal:  J Med Microbiol       Date:  1993-11       Impact factor: 2.472

View more
  3 in total

1.  Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review.

Authors:  Keiko Ando; Takashi Shimamoto; Tetsuzo Tauchi; Yoshikazu Ito; Yuzuru Kuriyama; Akihiko Gotoh; Keisuke Miyazawa; Yukihiko Kimura; Takashi Kawai; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

2.  Does seropositivity for Helicobacter pylori antibodies increase outpatient costs for gastric and duodenal ulcer or inflammation?

Authors:  Akira Babazono; Motonobu Miyazaki; Hiroshi Une; Eiji Yamamoto; Toshihide Tsuda; Yoshio Mino; Alan L Hillman
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  Helicobacter pylori infection in patients with autoimmune thrombocytopenic purpura.

Authors:  Erdal Kurtoglu; Ertugrul Kayacetin; Aysegul Ugur
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.